| ²é¿´: 647 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
scswpiyly½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Çë°ïæ·ÒëÒ»¶Î¹ØÓÚÉúÎïÒ½Ò©µÄ×ÊÁÏ£¬Ð»Ð»~
|
||
|
Adipocytes differentiate from preadipocytes. Transcription factors including PPAR¦Ã (peroxisome proliferator-activated receptor ¦Ã), C/EBP family (CCAAT/enhancer binding proteins; C/EBR¦Á, C/EBR¦Â and C/EBR¦Ä) and ADD1/SREBP1c (adipocyte determination differentiation factor 1)/(sterol regulatory element binding protein 1c) play a crucial role in adipocyte differentiation. The expression of these transcription factors is induced at different points of time in the course of adipocyte differentiation and they interact with one another to regulate adipocyte-specific genes and progressively induce fat metabolism and adipocyte differentiation . Accordingly, a material that has the activity of regulating differentiation from preadipocytes to adipocytes and/or fat accumulation in adipose tissues or suppressing the expression of PPAR¦Ã, C/EBR¦Á, and/or ADD1/SREBP1c may be used as an anti-obesity agent. As such, ginkgolide A or bilobalide isdisclosed in Korean Patent No. 920648, ginsenoside-Rf or compound K in Korean Patent No. 847252, and oltipraz inKorean Patent No. 576157. |
» ²ÂÄãϲ»¶
0817 »¯Ñ§¹¤³Ì 299·ÖÇóµ÷¼Á ÓпÆÑоÀú ÓжþÇøÎÄÕÂ
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸Î人Àí¹¤²ÄÁϹ¤³Ìר˶µ÷¼Á
ÒѾÓÐ5È˻ظ´
0856µ÷¼Á£¬ÊÇѧУ¾ÍÈ¥
ÒѾÓÐ7È˻ظ´
É격26Äê
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0703»¯Ñ§µ÷¼Á £¬Áù¼¶Òѹý£¬ÓпÆÑоÀú
ÒѾÓÐ12È˻ظ´
294Çóµ÷¼Á²ÄÁÏÓ뻯¹¤×¨Ë¶
ÒѾÓÐ13È˻ظ´
288Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
307Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸ÄϾ©Àí¹¤´óѧ085701×ÊÔ´Óë»·¾³302·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
¹Å¿É¤×
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
- ·ÒëEPI: 323
- Ó¦Öú: 91 (³õÖÐÉú)
- ¹ó±ö: 16.835
- ½ð±Ò: 19237.1
- É¢½ð: 40372
- ºì»¨: 275
- ɳ·¢: 183
- Ìû×Ó: 25406
- ÔÚÏß: 1082.3Сʱ
- ³æºÅ: 1034379
- ×¢²á: 2010-06-02
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
- ¹ÜϽ: µ¼Ê¦ÕÐÉú
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
Mally89: ½ð±Ò+1, ¸ÐлӦÖú£¡ 2012-06-21 19:55:33
scswpiyly: ½ð±Ò+15, ·ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú, thanks£¡ 2012-06-25 17:09:23
Mally89: ½ð±Ò+1, ¸ÐлӦÖú£¡ 2012-06-21 19:55:33
scswpiyly: ½ð±Ò+15, ·ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú, thanks£¡ 2012-06-25 17:09:23
| Ö¬·¾Ï¸°û²»Í¬ÓÚǰ֬·¾Ï¸°û¡£×ªÂ¼Òò×Ó°üÀ¨PPARy£¨¹ýÑõ»¯ÎïøÌåÔöÖ³ÎD»îÊÜÌ壩£¬C/EBP¼Ò×åµ°°×£¨CCAAT/ÔöÇ¿×Ó½áºÏµ°°×£¬ C/EBR¦Á, C/EBR¦Â and C/EBR¦Ä£©ÒÔ¼°ADD1/SREBP1c£¨Ö¬·¾Ï¸°û²â¶¨·Ö»¯Òò×Ó1£©/µ¨¹Ì´¼µ÷½ÚÔª¼þ½áºÏµ°°×1c£©ÔÚÖ¬·¾Ï¸°û·Ö»¯ÖаçÑÝ×ÅÖ÷ÒªµÄ×÷Óá£×ªÂ¼Òò×ӵıí´ï°üÀ¨Ö¬·¾Ï¸°û·Ö»¯ÆÚ¼ä·Ö»¯µãµÄʱ¼ä¡¢Ö¬·¾Ï¸°ûÓëÆäËûÖ¬·¾Ï¸°ûÏ໥µ÷½ÚÖ¬·¾Ï¸°ûרÊôÐÔ»ùÒò¡¢³ÌÐòÐÔÓÕµ¼Ö¬·¾´úлÒÔ¼°Ö¬·¾Ï¸°û·Ö»¯¡£Òò´Ë£¬¾ßÓн«Ç°Ö¬·¾Ï¸°ûµ÷½Ú·Ö»¯ÎªÖ¬·¾Ï¸°ûºÍ/»òʹ֬·¾ÀÛ»ýÔÚÖ¬·¾×éÖ¯»òÒÖÖÆPPAR¦Ã, C/EBR¦Á, and/or ADD1/SREBP1c±í´ïµÄ»îÐÔµÄÎïÖÊ£¬¶¼¿ÉÒÔÓÃ×÷¿¹·ÊÅÖ¼Á¡£±ÈÈ磬ÔÚº«¹ú¹«¿ª×¨ÀûºÅΪ920648µÄÒøÐÓÄÚõ¥A»ò°×¹ûÄÚõ¥£¬×¨ÀûºÅΪ847252µÄÈ˲ÎÔíÜÕ-rf»òk»¯ºÏÎרÀûºÅ576157µÄ°ÂÌæÆÕÀ¡£ |

3Â¥2012-06-21 17:12:08
scswpiyly
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 327.8
- ºì»¨: 1
- Ìû×Ó: 229
- ÔÚÏß: 12.7Сʱ
- ³æºÅ: 113650
- ×¢²á: 2005-11-22
- רҵ: Óлú¸ß·Ö×Ó¹¦ÄܲÄÁÏ
2Â¥2012-06-18 10:40:17













»Ø¸´´ËÂ¥